Melanie’s diverse litigation practice encompasses intellectual property, complex commercial, class actions, product liability, cannabis and technology disputes. She is the go-to Canadian litigation adviser for a wide array of world-leading clients. Melanie excels at litigating cases in emerging fields. She was counsel in the first biologic and biosimilar drug patent cases in addition to numerous precedent-setting trials, applications and appeals. Melanie works extensively with life sciences companies on complex litigation of all types. She also has broad experience in the software, tech and social media spaces, dealing with commercial, patent, trademark, copyright and licensing disputes. Melanie leverages her unique experiences to handle a wide variety of complex commercial disputes, adeptly devising strategic options and navigating cross-border issues. Consistently recognized as a leading litigator, Melanie was named the Canadian IP Litigator of the Year (2022 and 2023) and one of the Top 50 Women Litigators in Canada for several years by Benchmark; as a Rising Star: Leading Lawyers Under 40 by Lexpert; as one of the Top 250 Women in IP worldwide by Managing Intellectual Property IP Stars (one of only a few Canadians recognized); and in all major directories, including Chambers.
